Updates on Teclistamab, Talquetamab, and CARVYKTI | Mark Wildgust, PHD | ASH 2022

Interview with Mark Wildgust, PhD of Janssen at ASH 2022. Filmed December 10, 2022. The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at https://www.healthtree.org/myeloma/co... Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: https://give.healthtree.org/campaign/... HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/ Follow HealthTree: twitter.com/healthtreeformm facebook.com/healthtreeformultiplemyeloma instragram.com/healthtreeformultiplemyeloma

Can Multiple Myeloma Be Cured? CAR T & New Breakthroughs Explained: Myeloma QA Replay
▶︎

Can Multiple Myeloma Be Cured? CAR T & New Breakthroughs Explained: Myeloma QA Replay

Talquetamab (TALVEY)  -a GPRC5D x CD3  Bispecific Antibody for Multiple Myeloma
▶︎

Talquetamab (TALVEY) -a GPRC5D x CD3 Bispecific Antibody for Multiple Myeloma

Talquetamab and Teclistamab in RRMM: Updated Results from RedirecTT-1 | Yael Cohen, MD | IMS 2024
▶︎

Talquetamab and Teclistamab in RRMM: Updated Results from RedirecTT-1 | Yael Cohen, MD | IMS 2024

028 Myeloma in 2026 - What's Coming Next and Why It Matters
▶︎

028 Myeloma in 2026 - What's Coming Next and Why It Matters

IMS 2025 Highlight: Myeloma Treatment Is Changing Fast | Mohamad Mohty, MD, PhD | #IMS2025
▶︎

IMS 2025 Highlight: Myeloma Treatment Is Changing Fast | Mohamad Mohty, MD, PhD | #IMS2025

Kymriah® (tisagenlecleucel) Mechanism of Action in B-cell ALL and DLBCL
▶︎

Kymriah® (tisagenlecleucel) Mechanism of Action in B-cell ALL and DLBCL

TECVAYLI (Teclistamab) Everything You Need to Know- newer version available see link 👇
▶︎

TECVAYLI (Teclistamab) Everything You Need to Know- newer version available see link 👇

030 CAR-T Therapy Explained: A Personalised Treatment for Myeloma
▶︎

030 CAR-T Therapy Explained: A Personalised Treatment for Myeloma

Real-world efficacy & safety of teclistamab in patients with heavily pretreated R/R multiple myeloma
▶︎

Real-world efficacy & safety of teclistamab in patients with heavily pretreated R/R multiple myeloma

Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎

Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe

Managing the Unique Side Effects of Talquetamamb | Ajai Chari, MD | EHA 2024
▶︎

Managing the Unique Side Effects of Talquetamamb | Ajai Chari, MD | EHA 2024

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells
▶︎

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells

Can a keto diet eliminate cancer growth? Dr. Thomas Seyfried says yes
▶︎

Can a keto diet eliminate cancer growth? Dr. Thomas Seyfried says yes

Alfred Garfall: Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma
▶︎

Alfred Garfall: Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister
▶︎

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister

Cell-based therapies in IBD incl. hematopoetic stem cell transplantation & CAR T cell therapies
▶︎

Cell-based therapies in IBD incl. hematopoetic stem cell transplantation & CAR T cell therapies

What a Stroke Looks Like the Day Before It Hits — Know This to Protect Yourself
▶︎

What a Stroke Looks Like the Day Before It Hits — Know This to Protect Yourself

Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten
▶︎

Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten

Sundar Jagannath, MD, defines 'cure' in multiple myeloma
▶︎

Sundar Jagannath, MD, defines 'cure' in multiple myeloma

My Experience with Teclistamab for Multiple Myeloma Part 4
▶︎

My Experience with Teclistamab for Multiple Myeloma Part 4